DCVC

Activity from announced rounds

Activity in this selectionEnterprise software

DCVC is an investment firm identified by TypeSafe AI as an existing investor and by its own communications as a backer of Shennon Biotechnologies.

Recorded funding activity

TypeSafe turns unstructured inputs into typed decisions and probability scores for automated software. Shennon develops T-cell engager therapies for solid tumors. Separate TypeSafe financings remain separate events under one investor history.

Sources
Rounds participated in
5
Confirmed lead rounds
—
5 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$562M
5 disclosed · full round size, not this investor’s share

By stage

Series C+3
Series A2

By primary sector

Hardware2
Agritech1
Biotech1
Defense tech1

By country

United States3
New Zealand1
United Kingdom1

Rounds

5 in this selection
Atom Computing

Develops large-scale neutral-atom quantum computers for fault-tolerant commercial and government applications

$100MSeries C
Role not disclosed
Quantum Motion

Builds utility-scale quantum computers using industry-standard silicon transistors

$160MSeries C
Role not disclosed
Kanvas Biosciences

Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy

$48MSeries A
Role not disclosed
Halter

Develops GPS-enabled cattle collars using sensors, software and AI.

$220MSeries E
Role not disclosed
Chariot Defense

Chariot Defense develops power-distribution systems for military use.

$34MSeries A
Role not disclosed